keratin.com, hair loss, baldness, alopecia, disease, and treatment information

alopecia areata epidemiology and genetics

Hair Biology
Diagnosis / Decisions
Androgenetic Alopecia Biology
Androgenetic Alopecia Clinical Patterns
Androgenetic Alopecia Treatments
Hair Restoration
Alopecia Areata
Effluviums
Scarring Alopecias
Inflammatory Alopecias
Other Alopecias
Hair Shaft Defects
Infectious Hair Disease
Hirsutism / Hypertrichosis
Hair Color
Hair Cosmetics
Bits and Pieces
Immunology
Discussion Forums
Personal / Site Information

Human epidemiology suggests genes affect alopecia areata

It has been shown that there is a higher incidence of alopecia areata in genetically related individuals. This suggests that at least some people are genetically predisposed to develop alopecia areata. The triggers for the onset of alopecia areata may be environmental, but the resistance of the alopecia areata lesion to treatment, its persistence and regression, and its extent over the body may be influenced by the presence and interaction of multiple genes.

Several studies suggest alopecia areata may have a genetic basis (Colombe 1995, Van der Steen 1992). Alopecia areata with similar times of onset or similar hair loss patterns has been reported in monozygotic twins (identical twins) (Alsaleh 1995, Scerri 1992, Bonjean 1968, Cole 1984, Hendren 1949, Weidman 1956, Stankler 1979) and dizygotic (non-identical) twins (Traub 1935, Anderson 1937, Bereston 1951, Barsky 1961, Wolf 1984, Insler 1989). Families with several generations of alopecia areata affected individuals also suggest AA may be a genetically determined disease (Shelton 1942, Gol'dshtein 1978, Dawn 1996, Hordinsky 1984, Valsecchi 1985, Van der Steen 1992).

Epidemiological studies provide basic evidence for involvement of alopecia areata susceptibility genes. Numerous studies suggest alopecia areata may be more frequently expressed in genetically related individuals. Typically 10 to 20% and in one study up to 42% of patients with alopecia areata indicated at least one other affected family member. In contrast, the lifetime risk of alopecia areata expression in the general population has been suggested to be 1.7% (Safavi 1995). Familial incidence is probably significantly higher than reported in the studies as there is a tendency not to discuss hair loss, particularly in previous generations where patchy alopecia areata hair loss was sometimes mistaken for the socially unacceptable disease, syphilis (Ormsby 1948). Even today the marked psycho-social consequences of hair loss inhibit some individuals from seeking diagnosis and treatment. Some may not be aware of their hair loss if it is limited or develops in an area not immediately visible to the individual.

A strong association has been observed between alopecia areata and Down's syndrome. From 1000 patients and 1000 control subjects, Du Vivier and Munro observed 60 cases of Down's syndrome individuals with alopecia areata verses 1 control (Du Vivier 1975). Carter and Jegasothy identified 19 cases in 214 Down's patients and the statistical relationship is further supported in other studies (Carter 1976, Wunderlich 1965). The genetic mutation for autoimmune polyendocrinopathy syndrome type 1 (AIRE, autoimmune regulator gene, Finnish-German APECED Consortium 1997) is also associated with a 29 to 37% prevalence of alopecia areata (Betterle 1998). These studies suggest that candidate gene loci for alopecia areata susceptibility may be present on human Chromosome 21.

Associations of alopecia areata with other autoimmune diseases have also been reported. Between 7% and 27% of AA affected patients may also express a thyroid disease phenotype, including goiter presence, myxedema and Hashimoto's thyroiditis (Cunliffe 1969, Milgraum 1987, Shellow 1992, Pualvilai 1994). Co-expression of vitiligo and alopecia areata has also been reported at between 4% and 9% (Muller 1963, Main 1975). However, the statistical significance of these disease associations when compared to appropriate control populations has been disputed elsewhere (Salamon 1971, Gollnick 1992, Schallreuter 1994). Numerous case reports detail concordant presence of AA with other autoimmune diseases, such as diabetes and myasthenia gravis, although the statistical significance is unknown (McElwee 1998). This apparent asociation with other autoimmune diseases further supports the idea that alopecia areata is also an autoimmune disease. It may be that genes involved in one form of autoimmune disease can also contribute to the development of other autoimmune disease forms.

Overall then, many epidemiological studies support the notion that alopecia areata susceptibility is determined in part by genetics, at for a least some of those affected by the disease. Probably genetics contributes to alopecia areata in everyone who has it, but the contribution may be bigger and strogner in some while for others the environment plays a bigger role.


Human epidemiology suggests genes affect alopecia areata references

  • Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol. 1995 Nov;33(5 Pt 1):757-64.
  • van der Steen P, Traupe H, Happle R, Boezeman J, Strater R, Hamm H. The genetic risk for alopecia areata in first degree relatives of severely affected patients. An estimate. Acta Derm Venereol. 1992 Sep;72(5):373-5.
  • Sharma VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol. 1996 Sep-Oct;13(5):372-7.
  • Hordinsky MK, Hallgren H, Nelson D, Filipovich AH. Familial alopecia areata. HLA antigens and autoantibody formation in an American family. Arch Dermatol. 1984 Apr;120(4):464-8.
  • Du Vivier A, Munro DD. Alopecia areata, autoimmunity, and Down's syndrome. Br Med J. 1975 Jan 25;1(5951):191-2.
  • Carter DM, Jegasothy BV. Alopecia areata and Down syndrome. Arch Dermatol. 1976 Oct;112(10):1397-9.
  • Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet. 1997 Dec;17(4):399-403.
  • Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J Am Acad Dermatol. 1987 Jul;17(1):57-61.
  • Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol. 1994 Sep;33(9):632-3.
  • Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger J. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology.
  • McElwee KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP. Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology. 1998;66(2):90-107.
  • Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995 Jul;70(7):628-33.
  • Betterle C, Greggio NA, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998 Apr;83(4):1049-55.
  • Valsecchi R, Vicari O, Frigeni A, Foiadelli L, Naldi L, Cainelli T. Familial alopecia areata--genetic susceptibility or coincidence? Acta Derm Venereol. 1985;65(2):175-7.
  • Scerri L, Pace JL. Identical twins with identical alopecia areata. J Am Acad Dermatol. 1992 Nov;27(5 Pt 1):766-7.
  • Alsaleh QA, Nanda A, al-Hasawi F, el-Kashlan M. Concurrent appearance of alopecia areata in siblings. Pediatr Dermatol. 1995 Sep;12(3):285-6.
  • Bonjean M, Prime A, Avon P. Pelade chez deux jumeaux homozygotes (sic). Lyon Med 1968; 219: 1852-3.
  • Cole GW, Herzlinger D. Alopecia universalis in identical twins. Int J Dermatol. 1984 May;23(4):283.
  • Hendren S. Identical alopecia areata in identical twins. Arch Dermatol 1949; 60: 793-5.
  • Weidman AI, Zion LS, Mamelok AE. Alopecia areata occurring simultaneously in identical twins. Arch Dermatol 1956; 74: 424-6.
  • Stankler L. Synchronous alopecia areata in two siblings: a possible viral aetiology. Lancet 1979; 1: 1303-4.
  • Traub EF. Alopecia areata and alopecia totalis. Arch Dermatol Syph 1935; 32: 959
  • Anderson NP. Alopecia areata in two sisters. Arch Dermatol Syph 1937; 36: 871.
  • Bereston ES, Robinson HN. Alopecia areata occurring in two brothers and two sisters. Arch Dermatol Syph 1951; 64: 204-5.
  • Barsky S, Gigli I. Alopecia areata in twins. Arch Dermatol 1961; 83: 170.
  • Wolf D, Wolf R. Simultaneous alopecia areata in two siblings. J Am Acad Dermatol 1984; 11: 897-8.
  • Insler MS, Helm CJ. Alopecia areata including the cilia and eyebrows of two sisters. Ann Ophthalmol 1989; 21: 451-3.
  • Shelton JM, Hollander L. Alopecia totalis in father and daughter. Arch Dermatol Syph 1942; 46: 137-8.
  • Gol'dshtein LM, Chipizhenko VA. Familial alopecia areata. Vestn Dermatol Venerol 1978; 10: 36-8.
  • Ormsby OS, Montgomery H. Diseases of the skin, 7th Edition. London: Kimpton, 1948: 1365-75.
  • Wunderlich C, Braun-Falco O. Mongolismus und alopecia areata. Med Welt 1965; 10: 477-81.
  • Cunliffe WJ, Hall R, Stevenson CJ, Weightman D. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969; 81: 877-81.
  • Main RA, Robbie RB, Gray ES, Donald D, Horne CH. Smooth muscle antibodies and alopecia areata. Br J Dermatol 1975; 92: 389-93.
  • Salamon T, Musafija A, Milicevic M. Alopecia areata and diseases of the thyroid gland. Dermatologica 1971; 142: 62-3.
  • Gollinck H, Orfanos CE: Alopecia areata: pathogenesis and clinical picture. In: Orfanos CE, Happle R, eds. Hair and Hair Diseases. Berlin: Springer-Verlag, 1990: 529-69.

Top of the page

Copyright ©. All Rights Reserved
http://www.keratin.com
Top of the page